or allene-containing phosphine ligands by Zhou2c (up
to 93% ee) or Reddy2e (up to 95% ee), and the Rh(I)-
catalyzed addition to isatins using MeO-mop ligands
by Hayashi3a (up to 93% ee). However, to the best
of our knowledge, no successful examples of transition-
metal-catalyzed asymmetric addition of organometallic
reagents to R-diketones are known,7 although the nona-
symmetric version with arylstannanes or arylboronic acids
has already been reported in 2003 and 2007, respectively.4
Searching for an effective chiral catalyst to overcome the
challenge remaining in this asymmetric transformation is
therefore of great importance.
To realize the challenging asymmetric 1,2-addition to R-
diketones, a suitable chiral ligand is thus essential. As part
of our ongoing project on the development of novel alkene
ligands,8ꢀ11 recently, we found that simple sulfurꢀalkene
hybrid ligands derived from chiral tert-butanesulfinamide12
were effective for Rh(I)-catalyzed asymmetric 1,4-addition
of arylboronic acids to R,β-unsaturated carbonyl com-
pounds.13ꢀ15 To our pleasure, we found that chiral sulfurꢀ
alkene hybrid ligands were also highly effective for Rh(I)-
catalyzed 1,2-additions to R-diketones with as low as a
0.1 mol % catalyst loading to afford optically active tertiary
R-hydroxyketones. Herein, we report our preliminary
results on this subject.
Table 1. Optimization of Reaction Conditions for Rh(I)-
Catalyzed Asymmetric Addition of 4-Methoxyphenylboronic
Acid (2a) to Benzil (1a)a
cat. loading
(mol %)
time
(h)
temp
conv
(%)b
ee
(%)c
entry
base
(°C)
1
5.0
1.0
1.0
1.0
1.0
1.0
0.1
0.1
0.05
0.01
KOH
KOH
Et3N
K3PO4
K2CO3
KF
4
2
50
25
25
25
25
25
25
50
50
80
>99
>99
55
99
99
99
99
99
99
99
98
98
95
2
3
2
4
2
>99
86
5
2
6
2
75
7
KOH
KOH
KOH
KOH
24
3
51
8
9
>99
59
17
16
10
12
a All reactions were carried out with 1a (0.20 mmol), 2a (0.30 mmol),
catalyst loading as indicated (Rh/4a = 1/1.2), and base (1.5 equiv of Rh)
in dioxane/H2O (v/v = 2/1) (1.5 mL) unless other noted; for entries
7ꢀ10, reactions were run with 1a (2.0 mmol) and 2a (3.0 mmol) in
dioxane/H2O (v/v = 2/1) (3.0 mL). b The conversion was determined by
crude 1H NMR. c The ee was determined by chiral HPLC.
Under previously reported reaction conditions,15 ligand
4a was initially subjected to the Rh(I)-catalyzed asym-
metric addition of 4-methoxyphenylboronic acid (2a) to
benzil (1a). We were pleased to find that the reaction went
smoothly to afford the desired product 3a in quantitative
conversion with 99% ee (Scheme 1). This promising result
encouraged us toward further optimization of the reaction
conditions. As shown in Table 1, bases were found to have
some impact on reactivity but not on enantioselectivity
(entries 2ꢀ6). The activity of the Rh/4a catalyst proved to
Scheme 1. Initial Study on Rh(I)-Catalyzed Asymmetric Addi-
tion of 4-Methoxyphenylboronic Acid (2a) to Benzil (1a)
€
€
46, 3139. (h) Maire, P.; Breher, F.; Schonberg, H.; Grutzmacher, H.
€
Organometallics 2005, 24, 3207. (i) Hahn, B. T.; Tewes, F.; Frohlich, R.;
Glorius, F. Angew. Chem., Int. Ed. 2010, 49, 1143.
(11) For examples of alkene ligands developed by our group, see: (a)
Hu, X.; Zhuang, M.; Cao, Z.; Du, H. Org. Lett. 2009, 11, 4744. (b) Hu,
X.; Cao, Z.; Liu, Z.; Wang, Y.; Du, H. Adv. Synth. Catal. 2010, 352, 651.
(c) Cao, Z.; Du, H. Org. Lett. 2010, 12, 2602. (d) Wang, Y.; Hu, X.; Du,
H. Org. Lett. 2010, 12, 5482. (e) Liu, Z.; Du, H. Org. Lett. 2010, 12, 3054.
(f) Cao, Z.; Liu, Y.; Liu, Z.; Feng, X.; Zhuang, M.; Du, H. Org. Lett.
2011, 13, 2164. (g) Cao, Z.; Liu, Z.; Liu, Y.; Du, H. J. Org. Chem. 2011,
76, 6401. (h) Liu, Z.; Cao, Z.; Du, H. Org. Biomol. Chem. 2011, 9, 5369.
(12) For leading reviews, see: (a) Ellman, J. A.; Owens, T. D.; Tang,
T. P. Acc. Chem. Res. 2002, 35, 984. (b) Ellman, J. A. Pure Appl. Chem.
(7) During our preparation of the current manuscript, Xu and co-
workers reported a similar work using 3.0 mol % catalyst; see: Zhu, T.-S.;
Jin, S.-S.; Xu, M.-H. Angew. Chem., Int. Ed. DOI: 10.1002/anie.201106972.
(8) For leading reviews on chiral alkene ligands, see: (a) Glorius, F.
Angew. Chem., Int. Ed. 2004, 43, 3364. (b) Johnson, J. B.; Rovis, T.
ꢀ
2003, 75, 39. (c) Ferreira, F.; Botuha, C.; Chemla, F.; Perez-Luna, A.;
Ellman, J. A. Chem. Soc. Rev. 2009, 38, 1162. (d) Robak, M. T.;
Herbage, M. A.; Ellman, J. A. Chem. Rev. 2010, 110, 3600.
€
Angew. Chem., Int. Ed. 2008, 47, 840. (c) Defieber, C.; Grutzmacher, H.;
Carreira, E. M. Angew. Chem., Int. Ed. 2008, 47, 4482. (d) Shintani, R.;
Hayashi, T. Aldrichimica Acta 2009, 42, 31. (e) Feng, C.-G.; Xu, M.-H.;
Lin, G.-Q. Synlett 2011, 1345.
(9) For pioneering examples on chiral alkene ligands, see: (a) Hayashi,
T.; Ueyama, K.; Tokunaga, N.; Yoshida, K. J. Am. Chem. Soc. 2003, 125,
11508. (b) Fischer, C.; Defieber, C.; Suzuki, T.; Carreira, E. M. J. Am.
Chem. Soc. 2004, 126, 1628.
(10) For leading references on chiral alkene ligands, see: (a) Wang,
Z.-Q.; Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. J. Am. Chem. Soc. 2007, 129,
5336. (b) Gendrineau, T.; Chuzel, O.; Eijsberg, H.; Genet, J.-P.; Darses,
S. Angew. Chem., Int. Ed. 2008, 47, 7669. (c) Luo, Y.; Carnell, A. J.
Angew. Chem., Int. Ed. 2010, 49, 2750. (d) Pattison, G.; Piraux, G.; Lam,
H. W. J. Am. Chem. Soc. 2010, 132, 14373. (e) Maire, P.; Deblon, S.;
(13) For leading reviews on Rh-catalyzed 1,4-additions, see: (a)
Hayashi, T. Synlett 2001, 879. (b) Reference 1aꢀb. (c) Gennari, C.;
Monti, C.; Piarulli, U. Pure Appl. Chem. 2006, 78, 303. (d) Christoffers,
J.; Koripelly, G.; Rosiak, A.; Rossle, M. Synthesis 2007, 1279. (e)
Edwards, H. J.; Hargrave, J. D.; Penrose, S. D.; Frost, C. G. Chem.
Soc. Rev. 2010, 39, 2093.
(14) For examples on S/alkene hybrid ligands, see: (a) Thaler, T.;
Guo, L.-N.; Steib, A. K.; Raducan, M.; Karaghiosoff, K.; Mayer, P.;
Knochel, P. Org. Lett. 2011, 13, 3182. (b) Jin, S.-S.; Wang, H.; Xu, M.-H.
Chem. Commun. 2011, 47, 7230. (c) Qi, W.-Y.; Zhu, T.-S.; Xu, M.-H.
Org. Lett. 2011, 13, 3410. (d) Chen, G.; Gui, J.; Li, L.; Liao, J. Angew.
Chem., Int. Ed. 2011, 50, 7681. (e) Xue, F.; Li, X.; Wan, B. J. Org. Chem.
2011, 76, 7256.
(15) For examples on sulfurꢀalkene ligands developed in our group,
see: (a) Feng, X.; Wang, Y.; Wei, B.; Yang, J.; Du, H. Org. Lett. 2011, 13,
3300. (b) Feng, X.; Wei, B.; Yang, J.; Du, H. Org. Biomol. Chem. 2011, 9,
5927. (c) Wang, Y.; Feng, X.; Du, H. Org. Lett. 2011, 13, 4954.
€
€
€
€
€
Breher, F.; Geier, J.; Bohler, C.; Ruegger, H.; Schonberg, H.; Grutzmacher,
H. Chem.;Eur. J. 2004, 10, 4198. (f) Shintani, R.; Duan, W.-L.; Nagano, T.;
Okada, A.; Hayashi, T. Angew. Chem., Int. Ed. 2005, 44, 4611. (g) Defieber,
C.; Ariger, M. A.; Moriel, P.; Carreira, E. M. Angew. Chem., Int. Ed. 2007,
Org. Lett., Vol. 14, No. 2, 2012
625